124 related articles for article (PubMed ID: 14671122)
1. Structural and functional analysis of human cytomegalovirus US3 protein.
Misaghi S; Sun ZY; Stern P; Gaudet R; Wagner G; Ploegh H
J Virol; 2004 Jan; 78(1):413-23. PubMed ID: 14671122
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.
Lee S; Yoon J; Park B; Jun Y; Jin M; Sung HC; Kim IH; Kang S; Choi EJ; Ahn BY; Ahn K
J Virol; 2000 Dec; 74(23):11262-9. PubMed ID: 11070025
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
Chevalier MS; Johnson DC
J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
[TBL] [Abstract][Full Text] [Related]
4. Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein.
Lee S; Park B; Ahn K
J Virol; 2003 Feb; 77(3):2147-56. PubMed ID: 12525649
[TBL] [Abstract][Full Text] [Related]
5. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
Chevalier MS; Daniels GM; Johnson DC
J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association.
Gruhler A; Peterson PA; Früh K
Traffic; 2000 Apr; 1(4):318-25. PubMed ID: 11208117
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa).
Zhao Y; Biegalke BJ
Virology; 2003 Oct; 315(2):353-61. PubMed ID: 14585338
[TBL] [Abstract][Full Text] [Related]
10. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
Pande NT; Powers C; Ahn K; Früh K
J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus: host immune modulation by the viral US3 gene.
Liu Z; Winkler M; Biegalke B
Int J Biochem Cell Biol; 2009 Mar; 41(3):503-6. PubMed ID: 18992841
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
Noriega VM; Tortorella D
J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
[TBL] [Abstract][Full Text] [Related]
15. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
[TBL] [Abstract][Full Text] [Related]
16. A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.
Shin J; Park B; Lee S; Kim Y; Biegalke BJ; Kang S; Ahn K
J Virol; 2006 Jun; 80(11):5397-404. PubMed ID: 16699020
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion.
Park B; Kim Y; Shin J; Lee S; Cho K; Früh K; Lee S; Ahn K
Immunity; 2004 Jan; 20(1):71-85. PubMed ID: 14738766
[TBL] [Abstract][Full Text] [Related]
19. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human cytomegalovirus US3 gene products.
Liu W; Zhao Y; Biegalke B
Virology; 2002 Sep; 301(1):32-42. PubMed ID: 12359444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
